. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useBone Density/drug effectsBone Density Conservation Agents/therapeutic useClinical Trials, Phase II as TopicDrugs, InvestigationalHumansOsteoporosis/drug therapy
Substances: See more » Antibodies, MonoclonalBone Density Conservation AgentsDrugs, Investigationalromosozumab
Year: 2014 PMID: 25195210
Source DB: PubMed Journal: Duke Med Health News ISSN: 2153-8387